(DLX) Deluxe - Overview
Stock: Checks, Payment Processing, Analytics, Promotional Print
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 6.81% |
| Yield on Cost 5y | 4.45% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.3% |
| Payout Ratio | 40.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.3% |
| Relative Tail Risk | -13.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 10.72 |
| Character TTM | |
|---|---|
| Beta | 0.897 |
| Beta Downside | 1.115 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.93% |
| CAGR/Max DD | 0.43 |
Description: DLX Deluxe January 26, 2026
Deluxe Corporation (NYSE:DLX) delivers technology-enabled solutions to U.S. and Canadian small- and medium-sized businesses (SMBs) and financial institutions across four segments: Merchant Services, B2B Payments, Data Solutions, and Print. Its core offerings span card authorization, payment processing, treasury-management tools (e.g., lockbox, remote deposit capture), fraud-prevention services, and a suite of data, analytics, and printed-product services.
In FY 2023 the company generated approximately $2.8 billion in revenue, up about 5% year-over-year, with Merchant Services contributing roughly 43% ($1.2 B) and B2B Payments posting a 12% YoY increase driven by higher adoption of electronic invoicing among SMBs. Conversely, the legacy Print segment declined 8% as check volume continues to erode, reflecting broader digitization trends. The Data Solutions segment now accounts for ~15% of total revenue, buoyed by growing demand for marketing analytics and profitability reporting services.
Key macro drivers include the U.S. SMB digital-payments market, which is projected to grow at a ~10% CAGR through 2029, and the lingering pressure from elevated inflation that can suppress discretionary SMB spending-both factors that introduce upside upside potential and downside risk to Deluxe’s earnings outlook. For a deeper quantitative breakdown, the ValueRay platform offers a granular, real-time view of DLX’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 82.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.11 > 1.0 |
| NWC/Revenue: -0.15% < 20% (prev -1.64%; Δ 1.49% < -1%) |
| CFO/TA 0.09 > 3% & CFO 228.7m > Net Income 82.7m |
| Net Debt (1.48b) to EBITDA (377.8m): 3.91 < 3 |
| Current Ratio: 0.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.6m) vs 12m ago 1.77% < -2% |
| Gross Margin: 53.04% > 18% (prev 0.53%; Δ 5251 % > 0.5%) |
| Asset Turnover: 81.32% > 50% (prev 81.53%; Δ -0.21% > 0%) |
| Interest Coverage Ratio: 1.91 > 6 (EBITDA TTM 377.8m / Interest Expense TTM 125.1m) |
Altman Z'' 1.55
| A: -0.00 (Total Current Assets 399.2m - Total Current Liabilities 402.4m) / Total Assets 2.59b |
| B: 0.20 (Retained Earnings 517.8m / Total Assets 2.59b) |
| C: 0.09 (EBIT TTM 239.0m / Avg Total Assets 2.61b) |
| D: 0.28 (Book Value of Equity 533.3m / Total Liabilities 1.92b) |
| Altman-Z'' Score: 1.55 = BB |
Beneish M -2.99
| DSRI: 1.12 (Receivables 225.1m/202.2m, Revenue 2.12b/2.14b) |
| GMI: 1.00 (GM 53.04% / 53.20%) |
| AQI: 1.00 (AQ_t 0.79 / AQ_t-1 0.79) |
| SGI: 0.99 (Revenue 2.12b / 2.14b) |
| TATA: -0.06 (NI 82.7m - CFO 228.7m) / TA 2.59b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of DLX shares?
Over the past week, the price has changed by +9.35%, over one month by +18.17%, over three months by +50.27% and over the past year by +26.57%.
Is DLX a buy, sell or hold?
- StrongBuy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 28.7 | 5.7% |
| Analysts Target Price | 28.7 | 5.7% |
| ValueRay Target Price | 30.9 | 13.8% |
DLX Fundamental Data Overview January 24, 2026
P/E Forward = 5.6883
P/S = 0.5148
P/B = 1.6813
P/EG = 0.474
Revenue TTM = 2.12b USD
EBIT TTM = 239.0m USD
EBITDA TTM = 377.8m USD
Long Term Debt = 1.41b USD (from longTermDebt, last quarter)
Short Term Debt = 49.2m USD (from shortTermDebt, last quarter)
Debt = 1.50b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.48b USD (from netDebt column, last quarter)
Enterprise Value = 2.57b USD (1.09b + Debt 1.50b - CCE 25.8m)
Interest Coverage Ratio = 1.91 (Ebit TTM 239.0m / Interest Expense TTM 125.1m)
EV/FCF = 16.58x (Enterprise Value 2.57b / FCF TTM 154.8m)
FCF Yield = 6.03% (FCF TTM 154.8m / Enterprise Value 2.57b)
FCF Margin = 7.31% (FCF TTM 154.8m / Revenue TTM 2.12b)
Net Margin = 3.91% (Net Income TTM 82.7m / Revenue TTM 2.12b)
Gross Margin = 53.04% ((Revenue TTM 2.12b - Cost of Revenue TTM 994.8m) / Revenue TTM)
Gross Margin QoQ = 53.89% (prev 53.57%)
Tobins Q-Ratio = 0.99 (Enterprise Value 2.57b / Total Assets 2.59b)
Interest Expense / Debt = 2.03% (Interest Expense 30.5m / Debt 1.50b)
Taxrate = 28.48% (13.4m / 47.2m)
NOPAT = 170.9m (EBIT 239.0m * (1 - 28.48%))
Current Ratio = 0.99 (Total Current Assets 399.2m / Total Current Liabilities 402.4m)
Debt / Equity = 2.26 (Debt 1.50b / totalStockholderEquity, last quarter 663.9m)
Debt / EBITDA = 3.91 (Net Debt 1.48b / EBITDA 377.8m)
Debt / FCF = 9.54 (Net Debt 1.48b / FCF TTM 154.8m)
Total Stockholder Equity = 636.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.18% (Net Income 82.7m / Total Assets 2.59b)
RoE = 13.00% (Net Income TTM 82.7m / Total Stockholder Equity 636.3m)
RoCE = 11.66% (EBIT 239.0m / Capital Employed (Equity 636.3m + L.T.Debt 1.41b))
RoIC = 8.08% (NOPAT 170.9m / Invested Capital 2.12b)
WACC = 4.72% (E(1.09b)/V(2.59b) * Re(9.22%) + D(1.50b)/V(2.59b) * Rd(2.03%) * (1-Tc(0.28)))
Discount Rate = 9.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.69%
[DCF Debug] Terminal Value 86.95% ; FCFF base≈144.0m ; Y1≈153.5m ; Y5≈184.6m
Fair Price DCF = 88.71 (EV 5.47b - Net Debt 1.48b = Equity 3.99b / Shares 45.0m; r=5.90% [WACC]; 5y FCF grow 7.33% → 2.90% )
EPS Correlation: -43.76 | EPS CAGR: -3.79% | SUE: 2.43 | # QB: 2
Revenue Correlation: -81.17 | Revenue CAGR: -1.45% | SUE: 2.20 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.79 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=3.69 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+3.9% | Growth Revenue=+0.7%